Table 3 Leukocyte counts and inflammatory cytokines at baseline and follow up
Intervention group | Control group | P-value | |||
|---|---|---|---|---|---|
Baseline | Follow up | Baseline | Follow up | ||
Leukocyte counts | |||||
Total leukocyte count (103 cells/μl) | 5.145 (1.417) | 5.156 (1.337) | 5.184 (1.237) | 5.594 (1.370) | 0.04 |
Neutrophil count (103 cells/μl) | 3.014 (1.119) | 2.958 (1.135) | 3.131 (0.912) | 3.377 (1.061) | 0.05 |
Monoctye count (103 cells/μl) | 0.400 (0.370, 0.430) | 0.400 0.360, 0.440 | 0.400 (0.350, 0.450) | 0.400 (0.350, 0.450) | 0.63 |
Lymphocyte count (103 cells/μl) | 1.507 (0.414) | 1.523 (0.389) | 1.446 (0.497) | 1.612 (0.449) | 0.04 |
CD3+CD4+T cells (103cells/μl) | 0.748 (0.596, 0.900) | 0.682 (0.605, 0.759) | 0.659 (0.532, 0.786) | 0.763 (0.648, 0.878) | 0.02 |
CD3+CD8+ T cells (103cells/μl) | 0.474 (0.365, 0.583) | 0.402 (0.334, 0.470) | 0.360 (0.214, 0.506) | 0.409 (0.322, 0.496) | 0.05 |
CD4+:CD8+ ratio | 1.62 (1.36, 1.88) | 1.69 (1.40, 1.98) | 1.93 (1.51, 2.35) | 1.91 (1.49, 2.33) | 0.87 |
NK cells (103 cells/μl) | 0.200 (0.175, 0.225) | 0.206 (0.177, 0.235) | 0.176 (0.147, 0.205) | 0.174 (0.144, 0.292) | 0.46 |
Inflammatory cytokines | |||||
IL-6 (ρg/mL) | 1.599 (1.259, 1.906) | 1.692 (1.377, 2.007) | 1.755 (1.456, 2.054) | 1.942 (1.602, 2.282) | 0.93 |
TNF-α(ρg/mL) | 0.889 (0.779, 0.999) | 0.916 (0.767, 1.065) | 1.058 (0.895, 1.221) | 0.992 (0.870, 1.114) | 0.61 |